Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-075215
Filing Date
2024-06-26
Accepted
2024-06-26 17:10:00
Documents
3
Period of Report
2024-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2418321d1_6k.htm 6-K 12425
2 EXHIBIT 99.1 tm2418321d1_ex99-1.htm EX-99.1 19206
3 GRAPHIC tm248321d1_ex99-1img001.jpg GRAPHIC 3380
  Complete submission text file 0001104659-24-075215.txt   37597
Mailing Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076
Business Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076 49 7071 9883 0
CureVac N.V. (Filer) CIK: 0001809122 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39446 | Film No.: 241074462
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)